Open AccessNetwork Pharmacology Analysis of Orally Bioavailable SARS-CoV-2 Protease Inhibitor Shows Synergistic Targets to Improve Clinical Efficacy
Author(s) -
Arun Kumar
Publication year - 2021
Publication title -
biology engineering medicine and science reports
Language(s) - English
Resource type - Journals
ISSN - 2454-6895
DOI - 10.5530/bems.7.2.8
Subject(s) - proteases , bioavailability , pharmacology , protease inhibitor (pharmacology) , protease , ic50 , chemistry , virology , virus , biology , enzyme , in vitro , biochemistry , viral load , antiretroviral therapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom